Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gynostemma pentaphyllum extract is a botanical extract derived from the whole plant or leaves of Gynostemma pentaphyllum (commonly known as jiaogulan), a perennial climbing vine native to East Asia. The primary active constituents are dammarane-type triterpene saponins called gypenosides. The extract is used in traditional medicine and as a dietary supplement for its purported antioxidant and adaptogenic properties. Mechanistically, it has been shown to activate AMP-activated protein kinase (AMPK), which may contribute to effects on glucose metabolism and fat reduction[3][5]. Clinical studies suggest potential benefits in managing type 2 diabetes[2][5], obesity[3][5], fatty liver disease[2], dyslipidemia[5], immune modulation (such as asthma)[1][2], and possibly cancer[2]. Standardized extracts such as Actiponin and ActivAMP are available commercially.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gynostemma pentaphyllum extract.